Physician profile
Lisa Gilbert
NPI 1578075867
$3,434.11
in general payments reported to CMS, 2019-2025
18 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $894 · 2023: $1,183 · 2024: $846 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,218.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,032.43 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $836.48 | 2023-2025 | Descovy, Epclusa, Biktarvy |
| Janssen Products, LP | $174.94 | 2022 | |
| Janssen Biotech, INC. | $155.93 | 2022-2023 | Symtuza |
| Abiomed | $146.81 | 2023 | Impella |
| Si-Bone, INC. | $144.13 | 2023 | |
| Theratechnologies INC. | $130.00 | 2022 | |
| Hologic Sales and Service, LLC | $127.71 | 2024 | Aptima |
| Edwards Lifesciences Corporation | $125.78 | 2021 | |
| Abbvie INC. | $124.97 | 2023 | |
| Novo Nordisk INC | $114.73 | 2021 | |
| Hydrofera LLC | $91.41 | 2023 | Hydrofera Blue |
| Astrazeneca Pharmaceuticals LP | $85.86 | 2021-2022 | |
| Lilly USA, LLC | $41.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.24 | 2025 | Pifeltro, Delstrigo, Capvaxive |
| Janssen Scientific Affairs, LLC | $24.69 | 2022 | |
| Glaxosmithkline, LLC. | $22.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.